|
|
compound eye development
|
GO:0048749 |
1 |
0.238
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.229
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.203
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.177
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.163
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.159
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.153
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.151
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.149
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.145
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
25 |
0.141
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.140
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.138
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.137
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.136
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.134
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.133
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.130
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.121
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.117
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.112
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.112
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.111
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.111
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.111
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.111
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.109
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.108
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.107
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.106
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.106
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.102
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.098
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.098
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.098
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.094
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.092
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.092
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.091
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.090
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.089
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.088
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.088
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.087
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.087
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.086
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.086
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.084
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.083
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.081
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.081
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.081
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.080
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.078
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.078
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.077
|
Mouse |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.074
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.073
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.072
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.072
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.072
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.069
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.069
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.068
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.068
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.068
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.067
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.066
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.066
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.066
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.065
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.063
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.063
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.062
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.062
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.061
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.061
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.060
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.060
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.059
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.057
|
|
|
|
positive regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032436 |
23 |
0.056
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.056
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.056
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.055
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.055
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.055
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.054
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.053
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.053
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.053
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.052
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.051
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.051
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.051
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.051
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.050
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.050
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.050
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.049
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.049
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.049
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.049
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.049
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.047
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.046
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.046
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.046
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.045
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.044
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.044
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.044
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.043
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.043
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.043
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.042
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.042
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.042
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.042
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.041
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.041
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.041
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.041
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.040
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.040
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.039
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.039
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.039
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.039
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.038
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.038
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.037
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.037
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.036
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.036
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.035
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.035
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.035
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.035
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.035
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.035
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.035
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.034
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.034
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.034
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.034
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.034
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.033
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.033
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.033
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.033
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.033
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.033
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.033
|
Mouse |
|
|
activation of immune response
|
GO:0002253 |
138 |
0.033
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.033
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.033
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.032
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.032
|
Mouse |
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.032
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.032
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.032
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.032
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.032
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.031
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.031
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.030
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.030
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.030
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.030
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.030
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.030
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.030
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.029
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.029
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.029
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.029
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.029
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.029
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.028
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.028
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.028
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to dna damage
|
GO:1902229 |
14 |
0.028
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.027
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.027
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.027
|
|
|
|
regulation of protein sumoylation
|
GO:0033233 |
4 |
0.027
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.027
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
15 |
0.027
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.027
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.026
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.026
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.026
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.026
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.026
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.026
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.026
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.026
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.025
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.025
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.025
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.025
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.025
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.025
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.025
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.025
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.025
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.025
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.025
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.024
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.024
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.024
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.024
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.024
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.024
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.024
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.024
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.024
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.024
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.023
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.023
|
|
|
|
type i interferon production
|
GO:0032606 |
29 |
0.023
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.023
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.023
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.023
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.023
|
|
|
|
regulation of type i interferon production
|
GO:0032479 |
22 |
0.023
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.023
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.023
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.022
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.022
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.022
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.022
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.022
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.022
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.022
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.022
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.022
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.022
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.022
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.022
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.022
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.022
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.021
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.021
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.021
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.021
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.021
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.021
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.021
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.021
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.021
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.021
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.021
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.021
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.021
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.021
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.021
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.020
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.020
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.020
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.020
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.020
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.020
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.020
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.020
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.019
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.019
|
Mouse |
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.019
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.019
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.019
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.019
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.019
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.018
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.018
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.018
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.018
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.018
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.018
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.018
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.018
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.018
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.018
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.018
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.018
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.018
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.018
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.018
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.018
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.018
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.018
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.017
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.017
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.017
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.017
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.017
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.017
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.017
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.017
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.017
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.017
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.017
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.017
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.017
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.017
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.016
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.016
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.016
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.016
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.016
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.016
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.016
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.016
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.016
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.016
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.016
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.016
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.016
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.016
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.016
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.016
|
Mouse |
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.016
|
|
|
|
positive regulation of protein sumoylation
|
GO:0033235 |
3 |
0.016
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.016
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.015
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.015
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.015
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.015
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.015
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.015
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.015
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.015
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.015
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.015
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.015
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.015
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.015
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.015
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.015
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.015
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.015
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.015
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.015
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.015
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.015
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.015
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.015
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.015
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.015
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.015
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.015
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.015
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.014
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.014
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.014
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.014
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.014
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.014
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.014
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.014
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.014
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.014
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.014
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.014
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.014
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.014
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.014
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.014
|
|
|
|
cellular response to type i interferon
|
GO:0071357 |
10 |
0.014
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.014
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.014
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.014
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.014
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.014
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.014
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.014
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.014
|
|
|
|
positive regulation of response to dna damage stimulus
|
GO:2001022 |
14 |
0.014
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.014
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.014
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.014
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.014
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.014
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.014
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.014
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.014
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.014
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.013
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.013
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.013
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.013
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.013
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.013
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.013
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.013
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.013
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.013
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.013
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.013
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.013
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.013
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.013
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.013
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.013
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.013
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.013
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.013
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.013
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.013
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.013
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.013
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.013
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.013
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.013
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.013
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.013
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.013
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.013
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.013
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.013
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.012
|
|
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
23 |
0.012
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.012
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.012
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.012
|
Mouse |
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.012
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.012
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.012
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.012
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.012
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.012
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.012
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.012
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.012
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.012
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.012
|
|
|
|
negative regulation of innate immune response
|
GO:0045824 |
17 |
0.012
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.012
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.012
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.012
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.012
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.012
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.012
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.012
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.012
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.012
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.012
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.012
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.012
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.012
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.012
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.012
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.012
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.012
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.012
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.012
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.012
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.012
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.012
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.012
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.012
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.012
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.012
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.012
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.012
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.012
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.012
|
|
